Screening for unknown atrial fibrillation in older people: a feasibility study in community pharmacies

Lidia Staszewsky1, L Pasina2, U M Musazzi3,4

  • 1Laboratory of Clinical Pharmacology, Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, 20156, Milan, Italy. lidia.staszewsky@marionegri.it.

Insights

Community pharmacies can effectively screen older adults for atrial fibrillation (AF), a common heart arrhythmia. This accessible screening approach is feasible and well-accepted, aiding early detection and prevention.

Area of Science:

  • Cardiology
  • Public Health
  • Geriatrics

Background:

  • Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, increasing morbidity and mortality risks, particularly in aging populations.
  • Asymptomatic AF often goes undetected, highlighting the need for systematic screening to enable timely therapeutic interventions.
  • Community pharmacies offer a potential venue for accessible AF screening services targeting older adults.

Purpose of the Study:

  • To evaluate the technical feasibility of implementing an AF screening program in community pharmacies.
  • To assess the acceptance of a freely offered AF screening service by older adults and pharmacy professionals.
  • To identify undiagnosed cases of AF in the elderly population through community-based screening.

Main Methods:

  • A 2-month screening initiative was conducted across 20 pharmacies in a mixed rural-urban Italian health district.
  • A 30-second single-lead electrocardiogram (ECG) using a telemedicine device was employed for AF detection.
  • Participants included older adults aged 70 years and above, with a focus on community pharmacy accessibility.

Main Results:

  • Out of 335 eligible older adults, 289 (86.3%) participated in the screening program.
  • Cardiologists deemed 80% of the obtained ECG tracings as readable for diagnostic purposes.
  • The screening identified previously unknown cases of atrial fibrillation in 1.3% of the participants.

Conclusions:

  • The proposed AF screening model demonstrated technical feasibility and high acceptance rates among both healthcare professionals and the public.
  • Pharmacist training is recommended to enhance participation and optimize the performance of community pharmacy-based screening programs.
  • Community pharmacies represent a viable and effective setting for systematic AF screening in older populations, facilitating early diagnosis and management.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
36
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
21
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
65
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
16
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
28
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
20